Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

NCT02780609 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Melphalan
DRUG: Dexamethasone
PROCEDURE: Autologous Hematopoietic Cell Transplantation (HCT)
DRUG: Fosaprepitant

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]